Website News and Research

RSS

Review highlights essential neurological considerations for gender dysphoria care

Gender dysphoria involves distress caused by a mismatch between a person's gender identity and sex assigned at birth.

28 Oct 2026

Updated ASTRO guidelines recommend shorter radiation courses for prostate cancer

An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of hypofractionated radiation therapy for patients with localized prostate cancer.

27 Oct 2026

New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed encouraging signs of antitumor activity, according to a phase 1 trial published in The Journal of Nuclear Medicine's Late-Breaking Fast Track.

26 Oct 2026

Gut microbiome differences may explain varied sleep responses to hydrogen supplementation

Hiroshima University researchers investigated the effects of hydrogen supplementation on sleep quality in healthy human volunteers.

23 Oct 2026

Fish consumption may help reduce hypertensive disorders of pregnancy

A new prospective study from Japan explored whether fish consumption before and during pregnancy is linked to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia.

23 Oct 2026

Medicare is more broken than we thought

By Oct. 1, at least 2 million seniors will have received alarming notices: Their health plans — which they get through Medicare Advantage, the version of Medicare run by private health insurance companies — will disappear at the end of the year.

23 Oct 2026

Zylidac Bio and Prolific Machines partner to scale Prolific’s next-generation biologics manufacturing platform to GMP production

Zylidac Bio, a fully integrated biologics CDMO within the Zydus Lifesciences Limited (Zydus) group, and Prolific Machines, a biotechnology company advancing biologics development and manufacturing through integrated optogenetics-enabled solutions delivering breakthrough yields, superior on-target quality, and precise process control, today announced a partnership to scale Prolific's platform from early development through GMP production.

From Zylidac Bio LLC 22 Oct 2026

Newer anticoagulants linked to fewer strokes and deaths after brain bleeds

For people with atrial fibrillation (AFib), an irregular heartbeat, and intracranial hemorrhage, a type of stroke also known as a brain bleed, anticoagulant use was associated with a lower risk of an ischemic stroke and death, according to a new study published October 21, 2026, in Neurology®, the official medical journal of the American Academy of Neurology.

21 Oct 2026

Early heart rhythm control linked to fewer recurrent strokes

For people hospitalized with ischemic stroke and atrial fibrillation (AFib), restoring the heart's normal rhythm within eight weeks after stroke is associated with a lower risk of having another stroke, according to a new study published October 21, 2026, in Neurology®, the official medical journal of the American Academy of Neurology.

21 Oct 2026

Altered fatty acid metabolism drives glioblastoma growth and treatment resistance

Glioma is the most common primary malignant brain tumor in adults, and glioblastoma (GBM), particularly IDH (Isocitrate dehydrogenase)-wildtype disease, has the poorest prognosis.

21 Oct 2026

Japanese study links postpartum depression to mother-infant bonding difficulties

A Japanese study found that higher postpartum depression scores were associated with greater mother–infant bonding difficulties.

21 Oct 2026

Biological framework tracks postpartum vulvar tissue recovery timelines

A new biological model published in Sexual Medicine Reviews by Oxford University Press addresses why pain with sex after childbirth-reported by 60% of women at three months-persists for some long after hormones return to normal.

21 Oct 2026

Study identifies initial cellular events in autoimmune kidney inflammation

When immunity works well, the body steers clear of infection and disease. However, when the immune system goes awry, healthy cells can often end up in the firing line.

19 Oct 2026

First patient dosed in Phase 1 clinical trial of new cancer drug

On August 18, 2026, in Japan, the Department of New Experimental Therapeutics and Early-Phase 1 Drug Development Service at Kansai Medical University Hospital, led by Professor Toshio SHIMIZU, administered DS1025 to the first patient worldwide as part of a global, multicenter First-in-Human Phase 1 clinical trial sponsored by Daiichi Sankyo.

19 Oct 2026

Website News and Research

Review highlights essential neurological considerations for gender dysphoria care

Updated ASTRO guidelines recommend shorter radiation courses for prostate cancer

New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer

Gut microbiome differences may explain varied sleep responses to hydrogen supplementation

Fish consumption may help reduce hypertensive disorders of pregnancy

Medicare is more broken than we thought

Zylidac Bio and Prolific Machines partner to scale Prolific’s next-generation biologics manufacturing platform to GMP production

Newer anticoagulants linked to fewer strokes and deaths after brain bleeds

Early heart rhythm control linked to fewer recurrent strokes

Altered fatty acid metabolism drives glioblastoma growth and treatment resistance

Japanese study links postpartum depression to mother-infant bonding difficulties

Biological framework tracks postpartum vulvar tissue recovery timelines

Study identifies initial cellular events in autoimmune kidney inflammation

First patient dosed in Phase 1 clinical trial of new cancer drug

Researchers use AI to identify early-stage inhibitors for antiviral therapy

Poll: Most older adults rush Medicare choices despite major policy changes

Researchers identify molecular pathway that improves ultrasound-based bone defect healing

Epilepsy linked to higher risk of young-onset dementia

New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides

Opioid use disorder diagnoses spike among commercially insured Americans

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News